Adicet Bio, Inc.
NASDAQ:ACET
1.49 (USD) • At close September 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 24.99 | 9.73 | 17.903 | 0.995 | 8.181 | 558.524 | 546.951 | 510.179 | 499.69 | 499.69 | 444.388 | 412.428 | 346.631 | 322.646 | 359.591 |
| Cost of Revenue
| 6.098 | 5.009 | 0 | 0 | 0.125 | 0.08 | 0.005 | 411.517 | 395.476 | 401.419 | 401.419 | 362.356 | 346.59 | 292.476 | 267.026 | 292.286 |
| Gross Profit
| -6.098 | 19.981 | 9.73 | 17.903 | 0.87 | 8.101 | 558.519 | 135.434 | 114.703 | 98.271 | 98.271 | 82.032 | 65.838 | 54.155 | 55.62 | 67.305 |
| Gross Profit Ratio
| 0 | 0.8 | 1 | 1 | 0.874 | 0.99 | 1 | 0.248 | 0.225 | 0.197 | 0.197 | 0.185 | 0.16 | 0.156 | 0.172 | 0.187 |
| Reseach & Development Expenses
| 106.043 | 71.246 | 48.943 | 34.334 | 23.691 | 14.717 | 16.839 | 5.942 | 5.222 | 2.834 | 0 | 0 | 0 | 0 | 0.153 | 0.506 |
| General & Administrative Expenses
| 26.533 | 26.295 | 22.22 | 22.76 | 8.692 | 8.428 | 76.82 | 73.159 | 65.209 | 61.021 | 63.855 | 56.666 | 49.288 | 44.717 | 43.574 | 45.422 |
| Selling & Marketing Expenses
| -6.098 | 0 | 0 | 0 | 0 | 0 | -74.782 | -73.158 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 20.435 | 26.295 | 22.22 | 22.76 | 8.692 | 8.428 | 2.038 | 0.001 | 65.209 | 61.021 | 63.855 | 56.666 | 49.288 | 44.717 | 43.574 | 45.422 |
| Other Expenses
| 19.462 | -0.919 | -0.606 | -0.953 | 2.331 | 4.533 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 126.478 | 97.541 | 71.163 | 57.094 | 32.383 | 23.145 | 18.877 | 0.001 | 70.431 | 63.855 | 63.855 | 56.666 | 49.288 | 44.717 | 43.727 | 45.928 |
| Operating Income
| -132.576 | -72.551 | -61.433 | -39.191 | -31.388 | -14.964 | -18.882 | -0.001 | 44.272 | 34.416 | 34.416 | 25.366 | 16.55 | 9.438 | 11.893 | 21.377 |
| Operating Income Ratio
| 0 | -2.903 | -6.314 | -2.189 | -31.546 | -1.829 | -0.034 | -0 | 0.087 | 0.069 | 0.069 | 0.057 | 0.04 | 0.027 | 0.037 | 0.059 |
| Total Other Income Expenses Net
| -10.082 | 2.761 | -0.691 | -0.302 | 3.269 | 4.533 | -14.896 | -2.468 | 0.402 | 0.134 | 0.134 | -0.626 | 0.412 | 0.765 | 0.839 | 0.812 |
| Income Before Tax
| -142.658 | -69.79 | -62.124 | -39.493 | -28.119 | -9.888 | -33.778 | -0.001 | 44.674 | 34.55 | 34.55 | 24.74 | 16.962 | 10.203 | 12.732 | 22.189 |
| Income Before Tax Ratio
| 0 | -2.793 | -6.385 | -2.206 | -28.26 | -1.209 | -0.06 | -0 | 0.088 | 0.069 | 0.069 | 0.056 | 0.041 | 0.029 | 0.039 | 0.062 |
| Income Tax Expense
| 5.93 | -2.761 | -0.125 | -2.815 | 0.019 | -0.589 | 19.088 | 20.382 | 15.674 | 12.222 | 12.222 | 7.759 | 7.994 | 3.622 | 4.103 | 8.716 |
| Net Income
| -142.658 | -67.029 | -61.999 | -36.678 | -28.138 | -9.299 | -33.778 | -0.001 | 29 | 22.328 | 22.328 | 16.981 | 8.968 | 6.581 | 8.629 | 13.473 |
| Net Income Ratio
| 0 | -2.682 | -6.372 | -2.049 | -28.279 | -1.137 | -0.06 | -0 | 0.057 | 0.045 | 0.045 | 0.038 | 0.022 | 0.019 | 0.027 | 0.037 |
| EPS
| -3.31 | -1.63 | -2 | -5.01 | -1.88 | -0.31 | -1.26 | 0 | 1.18 | 0.94 | 0.94 | 0.73 | 0.4 | 0.3 | 0.4 | 0.63 |
| EPS Diluted
| -3.31 | -1.63 | -2 | -5.01 | -1.88 | -0.31 | -1.25 | 0 | 1.16 | 0.93 | 0.93 | 0.72 | 0.39 | 0.3 | 0.39 | 0.62 |
| EBITDA
| -126.478 | -69.71 | -61.948 | -39.359 | -26.881 | -8.666 | -18.877 | -0.001 | 54.865 | 43.616 | 43.616 | 34.309 | 24.034 | 13.229 | 14.696 | 24.712 |
| EBITDA Ratio
| 0 | -2.79 | -6.367 | -2.198 | -27.016 | -1.059 | -0.034 | -0 | 0.108 | 0.087 | 0.087 | 0.077 | 0.058 | 0.038 | 0.046 | 0.069 |